Innate Pharma SA SEC filings IPHA
Innate Pharma SA has 339 filings in SEC EDGAR's recent list, going back to Jan 31, 2014. Its latest annual report, Form 20-F, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jan 16, 2024 | — |
| CORRESP | Letter to the SEC | Jan 11, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 26, 2023 | — |
| EFFECT | Filing | Jan 28, 2021 | — |
| CORRESP | Letter to the SEC | Jan 27, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2021 | — |
| POS EX | Filing | Oct 17, 2019 | — |
| EFFECT | Filing | Oct 16, 2019 | — |
| EFFECT | Filing | Oct 16, 2019 | — |
| CERT | 8a cert | Oct 16, 2019 | — |
| CORRESP | Letter to the SEC | Oct 11, 2019 | — |
| CORRESP | Letter to the SEC | Oct 11, 2019 | — |
| 8-A12B | Filing | Oct 10, 2019 | — |
| SEC STAFF LETTER | Filing | Oct 1, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 5, 2019 | — |
| DRSLTR | Filing | Aug 30, 2019 | — |
| DRS/A | Filing | Aug 30, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2019 | — |
| DRSLTR | Filing | Jul 19, 2019 | — |
| DRS/A | Filing | Jul 19, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2019 | — |
| DRS | Filing | Jun 10, 2019 | — |
| D | Filing | Jan 31, 2014 | — |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IPHA (Nasdaq), IPHYF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Marseille
- SEC filer status
- Accelerated filer
- SEC CIK
- 1598599
- Former names
- Innate Pharma, SA (until Jan 31, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.